ESC 365 - RIVER: Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation.

ESC Professional Premium Access

RIVER: Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation.

Session: Latest science in pharmacotherapy

Topic: Prosthetic Heart Valves

Speaker: Professor R. Lopes (Durham, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Renato Lopes

Duke University Medical Center, Durham (United States of America)

24 presentations

0 follower

3 more presentations in this session

PHYSIC – Precision hypertension care, a randomized double-blind repeated cross-over trial

Speaker: Professor J. Sundstrom (Uppsala, SE)

CLEVER-ACS - Everolimus in acute coronary syndromes.

Speaker: Assistant Professor B. Stahli (Zurich, CH)

Empagliflozin in patients with acute myocardial infarction.

Speaker: Professor H. Sourij (Graz, AT)

Access the full session

Latest science in pharmacotherapy

Speakers: Professor R. Lopes, Professor J. Sundstrom, Assistant Professor B. Stahli, Professor H. Sourij

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources